<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Helix Biomedix Inc — News on 6ix</title>
    <link>https://6ix.com/company/helix-biomedix-inc</link>
    <description>Latest news and press releases for Helix Biomedix Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 12 Aug 2025 11:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/helix-biomedix-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835808a78dffbe2df0fb7ac.webp</url>
      <title>Helix Biomedix Inc</title>
      <link>https://6ix.com/company/helix-biomedix-inc</link>
    </image>
    <item>
      <title>X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership</title>
      <link>https://6ix.com/company/helix-biomedix-inc/news/x4-pharmaceuticals-announces-dollar60-million-equity-financing-with-concurrent-changes-in-management-and-board-leadership</link>
      <guid isPermaLink="true">https://6ix.com/company/helix-biomedix-inc/news/x4-pharmaceuticals-announces-dollar60-million-equity-financing-with-concurrent-changes-in-management-and-board-leadership</guid>
      <pubDate>Tue, 12 Aug 2025 11:00:00 GMT</pubDate>
      <description>$60 million PIPE financing led by Coastlands Capital, Bain Capital Life Sciences and New Enterprise Associates Newly appointed board and management team includes Dr. Adam Craig as Executive Chairman, John Volpone as President and David Kirske as Chief Financial Officer BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it has entered into a securities purchase a</description>
    </item>
  </channel>
</rss>